GBT
is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of sickle cell diseases... Read moreGBT
is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of sickle cell diseases... Read more
News
Oct 09, 2022
Indian Pharma Post
GBT: Pfizer acquires Global Blood Therapeutics
Oct 07, 2022
PMLiVE
GBT: Pfizer completes acquisition of Global Blood Therapeutics for $5.4bn
Oct 05, 2022
MarketScreener
GBT: Pfizer Completes Acquisition of Global Blood Therapeutics
Oct 05, 2022
MedicalMarketing& Media
GBT: Pfizer's dealmaking continues as GBT, Biohaven acquisitions close
Sep 16, 2022
Markets Insider
GBT: INVESTIGATION ALERT: Halper Sadeh LLC Investigates FBMS, GBT, MVBF
Sep 15, 2022
StreetInsider
Press Release: GBT : GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022
Sep 08, 2022
GlobeNewswire
Press Release: GBT : GBT and Sickle Cell Disease Association of America to Host 11th Annual Sickle Cell Disease Therapeutics Conference
Aug 09, 2022
iNVEZZ
GBT: Pfizer is acquiring Global Blood Therapeutics
Aug 08, 2022
Owler
Global Blood Therapeutics, Inc.: GBT's revenue changed from $210.87M in Mar 2022 to $234.86M in Jun 2022
Aug 03, 2022
GlobeNewswire
Press Release: Global Blood Therapeutics Inc : GBT Announces Participation at the Wedbush PacGrow Healthcare Conference
